News
In a new approach for tapping biomass as a sustainable raw material, scientists are reporting use of a Nobel-Prize-winning technology to transform plant “essential oils” — substances with the characteristic fragrance of the plant — into high-value ingredients for sunscreens, perfumes and other personal care products.
| 2 min read
Modest R&D increase proposed for fiscal year 2013.
| 1 min read
Berkeley Lab research finds utility customer-funded energy efficiency programs expanding across the United States; Midwest and South on the rise.
| 3 min read
Scientists are reporting development of the first practical way to make large amounts of a promising new anti-cancer substance that kills cancer cells differently than existing medicines.
| 1 min read
Doctoral student publishes results with consortium in journal Science.
| 3 min read
Berkeley scientists find that a critical transcription factor co-exists in two distinct states.
| 4 min read
In an advance toward stain-proof, spill-proof clothing, protective garments and other products that shrug off virtually every liquid — from blood and ketchup to concentrated acids — scientists are reporting development of new “superomniphobic” surfaces.
| 2 min read
A Kansas State University researcher is developing more efficient ways to save costs, time and energy when creating nanomaterials and lithium-ion batteries.
| 3 min read
Lands unsuited for food crops represent huge untapped resource to grow mixed species biomass for ethanol.
| 3 min read
NSF's PIRE program enables international collaborations in research and education to advance scientific solutions to daunting global challenges.
| 5+ min read
U.S. Department of Agriculture (USDA) scientists and university cooperators have developed a biodegradable plastic that could be used in disposable food containers. The plastic, called a thermoplastic, becomes soft when heated.
| 2 min read
The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.
| 2 min read
